Praxsyn (Praxsyn) Days Payable : 42.16 (As of Sep. 2015)

View and export this data going back to 2007. Start your Free Trial

What is Praxsyn Days Payable?

Praxsyn's average Accounts Payable for the three months ended in Sep. 2015 was $1.35 Mil. Praxsyn's Cost of Goods Sold for the three months ended in Sep. 2015 was $2.92 Mil. Hence, Praxsyn's Days Payable for the three months ended in Sep. 2015 was 42.16.

The historical rank and industry rank for Praxsyn's Days Payable or its related term are showing as below:

PXYN's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 87.13
* Ranked among companies with meaningful Days Payable only.

Praxsyn's Days Payable declined from Sep. 2014 (42.95) to Sep. 2015 (42.16). It may suggest that Praxsyn accelerated paying its suppliers.

Praxsyn Days Payable Historical Data

The historical data trend for Praxsyn's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn Days Payable Chart

Praxsyn Annual Data

Trend

Oct05

Oct06

Oct07

Oct08

Oct09

Dec10

Dec11

Dec12

Dec13

Dec14

Days Payable

Get a 7-Day Free Trial

126.42

110.24

100.31

34.30

Praxsyn Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Days Payable	Get a 7-Day Free Trial															42.95	37.04	49.09	55.59	42.16

Competitive Comparison of Praxsyn's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Praxsyn's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Praxsyn's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Praxsyn's Days Payable distribution charts can be found below:

* The bar in red indicates where Praxsyn's Days Payable falls into.

Praxsyn Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Praxsyn's Days Payable for the fiscal year that ended in Dec. 2014 is calculated as

	Days Payable (A: Dec. 2014 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2013 )	+	Accounts Payable (A: Dec. 2014 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2014 )	*	Days in Period
=	( (0.191	+	0.483)	/	2 )	/	3.586	*	365
=	0.337					/	3.586	*	365
=	34.30

Praxsyn's Days Payable for the quarter that ended in Sep. 2015 is calculated as:

	Days Payable (Q: Sep. 2015 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2015 )	+	Accounts Payable (Q: Sep. 2015 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2015 )	*	Days in Period
=	( (1.726	+	0.975)	/	2 )	/	2.923	*	365 / 4
=	1.3505					/	2.923	*	365 / 4
=	42.16

Praxsyn Days Payable Related Terms

Thank you for viewing the detailed overview of Praxsyn's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Praxsyn (Praxsyn) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101

Website

http://www.praxsyncorp.com

Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.